Diplomat Pharmacy is seeing the fruits of its medicine-peddling labors. Doing business as Diplomat Specialty Pharmacy, the company has grown into one of the largest privately-held specialty pharmacies in the US. It contracts with health care entities, drugmakers, and benefit providers to deliver specialty medications to patients with chronic illnesses such as arthritis, cancer, hepatitis C, HIV/AIDS, kidney disease, and multiple sclerosis. Diplomat Specialty Pharmacy also provides disease management programs, care coordination, and compounding, among other services. Founded by Dale Hagerman in 1975, the company is today owned by son and CEO Phil Hagerman and other executives.
Diplomat Specialty Pharmacy has pharmacy locations and distribution centers in California, Florida, Illinois, and Michigan.
As a specialty pharmacy, Diplomat manages the distribution of drugs that require special handling or customized packaging (such as refrigeration or freeze-drying), including drugs that must be supplied directly to patients or treatment clinics on a regular basis. Such medicines include biotech drugs and dialysis and chemotherapy compounds that traditional pharmacies are not equipped to handle. Diplomat Specialty Pharmacy also provides compounding (mixing) and packaging services for some products.
Sales and Marketing
To expand its network of customers, Diplomat Specialty Pharmacy enters drug delivery service contracts with health care facilities, including cancer clinics and dialysis centers. It also provides product launch support and drug trial assistance to pharmaceutical manufacturers.
Diplomat Specialty Pharmacy's strategy of investing heavily in its technology systems and leadership team and keeping a sharp focus on patient care are paying off. The company provides a number of services to monitor and assist patients, including employing nurse wellness coordinators, nutritionists, and condition educators. It also expands its product offerings by entering new distribution agreements with pharmaceutical firms. For instance, in 2012 it agreed to act as the sole distributor for Regeneron's EYLEA, a newly launched injection for treatment of macular degeneration.
The company moved into a new headquarters building in Flint, Michigan, in 2011: A renovated 350,000-sq.-ft. building within a sprawling complex formerly occupied by GM. The project added several state-of-the-art facilities, including a national distribution hub, an advanced compounding laboratory (to make customized medication formulations), a training and education center, a high-tech software development and data center, and a national patient call center. – less